YBGJ
Yubo International Biotech Limited
Price Chart
Latest Quote
$0.01
Current Price| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 70,010 |
Stock Information
| Shares Outstanding | 170.42M |
| Total Debt | $1.38M |
| Cash Equivalents | $11K |
| Revenue | $-18 |
| Net Income | $-1.11M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $1.96M |
| EPS (TTM) | $-0.02 |
| Exchange | OQB |
đ Custom Metrics & Score
Score: 8/42| Debt to Equity | -0.14 |
| Debt to Earnings | 180.80 |
| Current Ratio | 0.14 |
| Quick Ratio | 0.10 |
| Avg Revenue Growth | -24.93% |
| Profit Margin | -51161.47% |
| Return on Equity | 51.84% |
| Avg FCF Growth | -3.91% |
| FCF Yield | -68.26% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.01 | 0 |
| 2026-01-30 | $0.01 | 0 |
| 2026-01-29 | $0.01 | 0 |
| 2026-01-28 | $0.01 | 0 |
| 2026-01-27 | $0.01 | 0 |
| 2026-01-26 | $0.01 | 148,010 |
| 2026-01-23 | $0.01 | 0 |
| 2026-01-22 | $0.01 | 0 |
| 2026-01-21 | $0.01 | 0 |
| 2026-01-20 | $0.01 | 0 |
| 2026-01-16 | $0.01 | 0 |
| 2026-01-15 | $0.01 | 0 |
| 2026-01-14 | $0.01 | 0 |
| 2026-01-13 | $0.01 | 0 |
| 2026-01-12 | $0.01 | 0 |
| 2026-01-09 | $0.01 | 0 |
| 2026-01-08 | $0.01 | 0 |
| 2026-01-07 | $0.01 | 0 |
| 2026-01-06 | $0.01 | 0 |
| 2026-01-05 | $0.01 | 0 |
About Yubo International Biotech Limited
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. Yubo International Biotech Limited is headquartered in Beijing, China.
đ° Latest News
No news articles available at the moment. Check back later for updates on YBGJ.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $821 | $185,491 | $51,631 | $423,727 |
| Cost Of Revenue | $822 | $185,491 | $51,631 | $423,726 |
| Total Revenue | $3,470 | $604,676 | $104,283 | $1,244,373 |
| Operating Revenue | $3,470 | $604,676 | $104,283 | $1,244,373 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Expenses | $1,773,389 | $1,799,382 | $1,309,506 | $2,787,238 |
| Rent Expense Supplemental | $390,150 | $489,591 | $362,346 | $628,656 |
| Other Income Expense | $-211,923 | - | - | - |
| Net Non Operating Interest Income Expense | $50 | $-377 | $229 | $427 |
| Total Other Finance Cost | $-50 | $377 | $-229 | $-427 |
| Operating Expense | $1,772,567 | $1,613,891 | $1,257,875 | $2,363,512 |
| Other Operating Expenses | $341,765 | $316,401 | $228,820 | $802,313 |
| General And Administrative Expense | $1,247,505 | $1,107,478 | $1,037,066 | $1,310,574 |
| Selling And Marketing Expense | - | $0 | $9,582 | $182,369 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-1,775,303 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Net Interest Income | $50 | $-377 | $229 | $427 |
| Normalized Income | $-1,563,380 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Net Income From Continuing And Discontinued Operation | $-1,775,303 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Total Operating Income As Reported | $-1,769,919 | $-1,194,706 | $-1,205,223 | $-1,542,865 |
| Net Income Common Stockholders | $-1,775,303 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Net Income | $-1,775,303 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Net Income Including Noncontrolling Interests | $-1,981,792 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Net Income Continuous Operations | $-1,981,792 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Pretax Income | $-1,981,792 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Special Income Charges | $-211,923 | $0 | - | - |
| Operating Income | $-1,769,919 | $-1,194,706 | $-1,205,223 | $-1,542,865 |
| Depreciation Amortization Depletion Income Statement | $183,297 | $190,012 | $27,537 | $21,402 |
| Depreciation And Amortization In Income Statement | $183,297 | $190,012 | $27,537 | $21,402 |
| Amortization Of Intangibles Income Statement | $13,422 | $11,700 | $9,439 | $8,180 |
| Depreciation Income Statement | $169,875 | $178,312 | $18,098 | $13,222 |
| Gross Profit | $2,648 | $419,185 | $52,652 | $820,647 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-0.02 | $-0.01 | $-0.01 | $-0.01 |
| Basic EPS | $-0.02 | $-0.01 | $-0.01 | $-0.01 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,374,698 | $-1,004,694 | $-1,177,686 | $-1,521,463 |
| Total Unusual Items | $-211,923 | $0 | - | - |
| Total Unusual Items Excluding Goodwill | $-211,923 | $0 | - | - |
| Reconciled Depreciation | $183,298 | $190,012 | $27,537 | $21,401 |
| EBITDA (Bullshit earnings) | $-1,586,621 | $-1,004,694 | $-1,177,686 | $-1,521,463 |
| EBIT | $-1,769,919 | $-1,194,706 | $-1,205,223 | $-1,542,865 |
| Diluted Average Shares | $119,820,790 | $119,820,790 | $118,721,045 | $118,130,820 |
| Basic Average Shares | $119,820,790 | $119,820,790 | $118,721,045 | $118,130,820 |
| Diluted NI Availto Com Stockholders | $-1,775,303 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Minority Interests | $206,489 | $0 | - | - |
| Tax Provision | $0 | $0 | $0 | $0 |
| Write Off | $211,923 | $0 | - | - |
| Amortization | $13,422 | $11,700 | $9,439 | $8,180 |
| Selling General And Administration | $1,247,505 | $1,107,478 | $1,046,648 | $1,492,943 |
| Rent And Landing Fees | $390,150 | $489,591 | $362,346 | $628,656 |
| Salaries And Wages | $857,355 | $617,887 | $674,720 | $681,918 |
| Provision For Doubtful Accounts | - | $0 | $-45,130 | $46,854 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-3,474,988 | $-1,898,111 | $-633,052 | $-170,074 |
| Total Assets | $1,534,831 | $1,667,269 | $2,348,551 | $4,587,233 |
| Total Non Current Assets | $851,990 | $942,032 | $1,598,539 | $3,528,889 |
| Non Current Prepaid Assets | $116,881 | $120,502 | $123,709 | $152,157 |
| Goodwill And Other Intangible Assets | $50,523 | $54,408 | $67,679 | $38,876 |
| Other Intangible Assets | $50,523 | $54,408 | $67,679 | $38,876 |
| Current Assets | $682,751 | $725,235 | $750,012 | $1,058,344 |
| Prepaid Assets | $196,417 | $138,673 | $64,253 | $306,978 |
| Inventory | $36,953 | $214,575 | $322,173 | $164,302 |
| Receivables | $442,366 | $365,628 | $345,366 | $559,547 |
| Accounts Receivable | $164,984 | $79,654 | $51,932 | $161,957 |
| Cash Cash Equivalents And Short Term Investments | $7,015 | $6,359 | $18,220 | $27,517 |
| Cash And Cash Equivalents | $7,015 | $6,359 | $18,220 | $27,517 |
| Cash Financial | $7,015 | $6,359 | $18,220 | $27,517 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $478,765 | $391,913 | $790,499 | $2,693,984 |
| Long Term Debt And Capital Lease Obligation | $110,773 | $115,527 | $390,445 | $1,928,401 |
| Current Debt And Capital Lease Obligation | $367,992 | $276,386 | $400,054 | $765,583 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $4,832,522 | $3,510,972 | $2,913,924 | $4,718,431 |
| Total Non Current Liabilities Net Minority Interest | $110,773 | $115,527 | $390,445 | $1,928,401 |
| Current Liabilities | $4,721,749 | $3,395,445 | $2,523,479 | $2,790,030 |
| Current Deferred Liabilities | $424,026 | $434,151 | $459,970 | $484,956 |
| Payables And Accrued Expenses | $3,929,731 | $2,684,907 | $1,663,455 | $1,539,491 |
| Payables | $3,929,731 | $2,684,907 | $1,663,455 | $1,539,491 |
| Accounts Payable | $1,037,836 | $825,631 | $549,838 | $275,831 |
| Other Current Liabilities | - | $1 | - | - |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $-3,424,465 | $-1,843,703 | $-565,373 | $-131,198 |
| Total Equity Gross Minority Interest | $-3,297,691 | $-1,843,703 | $-565,373 | $-131,198 |
| Stockholders Equity | $-3,424,465 | $-1,843,703 | $-565,373 | $-131,198 |
| Gains Losses Not Affecting Retained Earnings | $127,044 | $-13,204 | $70,043 | $118,453 |
| Other Equity Adjustments | $127,044 | $-13,204 | $70,043 | $118,453 |
| Retained Earnings | $-6,660,812 | $-4,885,509 | $-3,690,426 | $-2,485,432 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $119,820,790 | $119,820,790 | $119,820,790 | $118,182,332 |
| Share Issued | $119,820,790 | $119,820,790 | $119,820,790 | $118,182,332 |
| Tangible Book Value | $-3,474,988 | $-1,898,111 | $-633,052 | $-170,074 |
| Invested Capital | $-3,424,465 | $-1,843,703 | $-565,373 | $-131,198 |
| Working Capital | $-4,038,998 | $-2,670,210 | $-1,773,467 | $-1,731,686 |
| Capital Lease Obligations | $478,765 | $391,913 | $790,499 | $2,693,984 |
| Total Capitalization | $-3,424,465 | $-1,843,703 | $-565,373 | $-131,198 |
| Minority Interest | $126,774 | $0 | - | - |
| Additional Paid In Capital | $2,989,483 | $2,935,190 | $2,935,190 | $2,117,599 |
| Capital Stock | $119,820 | $119,820 | $119,820 | $118,182 |
| Common Stock | $119,820 | $119,820 | $119,820 | $118,182 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $110,773 | $115,527 | $390,445 | $1,928,401 |
| Current Deferred Revenue | $424,026 | $434,151 | $459,970 | $484,956 |
| Current Capital Lease Obligation | $367,992 | $276,386 | $400,054 | $765,583 |
| Dueto Related Parties Current | $2,891,895 | $1,859,276 | $1,113,617 | $1,263,660 |
| Net PPE | $684,586 | $767,122 | $1,407,151 | $3,337,856 |
| Accumulated Depreciation | $-21,685 | $-186,417 | $-38,434 | $-22,921 |
| Gross PPE | $706,271 | $953,539 | $1,445,585 | $3,360,777 |
| Leases | $187,186 | $514,288 | $282,681 | $33,196 |
| Other Properties | $18,900 | $19,826 | $20,343 | $22,106 |
| Machinery Furniture Equipment | $21,420 | $27,512 | $28,230 | $30,675 |
| Buildings And Improvements | $478,765 | $391,913 | $790,499 | $2,693,984 |
| Properties | $0 | $0 | $0 | $0 |
| Other Inventories | $36,953 | $1,627 | $2,815 | $73,688 |
| Finished Goods | $0 | $212,948 | $268,464 | $41,943 |
| Duefrom Related Parties Current | $277,382 | $285,974 | $293,434 | $397,590 |
| Construction In Progress | - | $0 | $323,832 | $580,816 |
| Raw Materials | - | $47,718 | $50,894 | $48,671 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-1,337,729 | $-738,971 | $-640,725 | $-1,585,579 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-1,337,729 | $-738,971 | $-600,953 | $-1,020,861 |
| Cash Flow From Continuing Operating Activities | $-1,337,731 | $-738,971 | $-600,953 | $-1,020,861 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Investing Cash Flow | $118,431 | $0 | $-39,772 | $-564,718 |
| Cash Flow From Continuing Investing Activities | $118,431 | $0 | $-39,772 | $-564,718 |
| Capital Expenditure | - | - | $-39,772 | $-564,718 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Financing Cash Flow | $1,407,139 | $745,659 | $669,186 | $127,164 |
| Cash Flow From Continuing Financing Activities | $1,407,139 | $745,659 | $669,186 | $127,164 |
| Net Other Financing Charges | $1,407,139 | $745,659 | $669,186 | $127,164 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $7,015 | $6,359 | $18,220 | $27,517 |
| Beginning Cash Position | $6,359 | $18,220 | $27,517 | $1,382,524 |
| Effect Of Exchange Rate Changes | $-187,185 | $-18,549 | $-37,758 | $103,408 |
| Changes In Cash | $187,841 | $6,688 | $28,461 | $-1,458,415 |
| Net PPE Purchase And Sale | $118,431 | $0 | $0 | $-564,718 |
| Sale Of PPE | $118,431 | $0 | - | - |
| Change In Working Capital | $248,840 | $266,100 | $576,504 | $492,493 |
| Change In Other Working Capital | $-10,126 | $-25,819 | $-24,986 | $-283,968 |
| Change In Payables And Accrued Expense | $212,205 | $275,794 | $274,007 | $1,346,365 |
| Change In Prepaid Assets | $-54,123 | $-71,211 | $271,173 | $-345,164 |
| Change In Inventory | $177,622 | $107,598 | $-157,871 | $-97,157 |
| Change In Receivables | $-76,738 | $-20,262 | $214,181 | $-127,583 |
| Changes In Account Receivables | $-85,330 | $-27,722 | $110,025 | $-159,641 |
| Other Non Cash Items | $2 | - | - | - |
| Provisionand Write Offof Assets | $211,923 | $0 | - | - |
| Depreciation Amortization Depletion | $183,298 | $190,012 | $27,537 | $21,401 |
| Depreciation And Amortization | $183,298 | $190,012 | $27,537 | $21,401 |
| Amortization Cash Flow | $13,422 | $11,700 | $9,439 | - |
| Amortization Of Intangibles | $13,422 | $11,700 | $9,439 | - |
| Depreciation | $169,875 | $178,312 | $18,098 | - |
| Net Income From Continuing Operations | $-1,981,792 | $-1,195,083 | $-1,204,994 | $-1,542,438 |
| Net Intangibles Purchase And Sale | - | $0 | $-39,772 | $0 |
| Purchase Of Intangibles | - | $0 | $-39,772 | $0 |
| Purchase Of PPE | - | - | $0 | $-564,718 |
| Change In Payable | - | - | $943,193 | $1,346,365 |
| Change In Account Payable | - | - | $274,007 | $174,656 |
| Asset Impairment Charge | - | - | $0 | $7,683 |